FISHVAC
Improving vaccination of carp against spring viraemia of carp virus (SVCV)
| Coordinatore | WAGENINGEN UNIVERSITY
Organization address
address: DROEVENDAALSESTEEG 4 contact info |
| Nazionalità Coordinatore | Netherlands [NL] |
| Totale costo | 177˙685 € |
| EC contributo | 177˙685 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2010-IEF |
| Funding Scheme | MC-IEF |
| Anno di inizio | 2011 |
| Periodo (anno-mese-giorno) | 2011-12-01 - 2013-11-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
WAGENINGEN UNIVERSITY
Organization address
address: DROEVENDAALSESTEEG 4 contact info |
NL (WAGENINGEN) | coordinator | 177˙685.60 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'This project aims at the advancement on fundamental knowledge on the evolution of fish cytokines and at the development of vaccination strategies against highly cytopathic virus of carp, taking as studying model SVCV. Worldwide, common carp is the most cultured fish species for food consumption with a value of US$20 billion. Koi carp are ornamental varieties of common carp and individual fish may exceed US$100.000 in value, making koi the most expensive fish in the world. However, virus infections are causing substantial economic losses in this market so there is an urgent need for the development of safe and efficacious vaccines that induce protective memory but, at present, virtually nothing is known regarding the immune response of carp to these viruses. The first aim of this project is the characterization of the immune responses of carp to SVCV infections. Specially, the study of those cytokines which are crucial for the development of protective cellular immune responses against viral infections, such as interferon alpha-beta (INFab) which has already considered to be a putative signal-3 cytokine (required for optimal programming for survival, effector function and memory of CD8 T cells). Therefore, the second aim is the characterization of bioactivity of carp-INFab which we hypothesize can be used as a molecular adjuvant to optimize vaccination against SVCV. The third aim is the development of vaccination protocols based on protective immunity induced by a new generation vaccine, a ‘INFab-adjuvated’ DNA vaccine against SVCV. The combined use of fundamental and applied approaches will provide the scientific rationale necessary for an improved development of safe and efficacious vaccines against deadly viruses of carp.'
Introduzione (Teaser)
In immune responses against various pathogens, blood cells communicate through the release of specialised molecules known as interferons (IFNs). European researchers are exploiting these molecules to develop a vaccine against the virus that causes Spring Viraemia of Carp (SVC) in fish.